These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20361918)

  • 1. Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial.
    Zisook S; Kasckow JW; Lanouette NM; Golshan S; Fellows I; Vahia I; Mohamed S; Rao S
    J Clin Psychiatry; 2010 Jul; 71(7):915-22. PubMed ID: 20361918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial.
    Zisook S; Kasckow JW; Golshan S; Fellows I; Solorzano E; Lehman D; Mohamed S; Jeste DV
    J Clin Psychiatry; 2009 Apr; 70(4):562-71. PubMed ID: 19192468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The InterSePT scale for suicidal thinking reliability and validity.
    Lindenmayer JP; Czobor P; Alphs L; Nathan AM; Anand R; Islam Z; Chou JC;
    Schizophr Res; 2003 Sep; 63(1-2):161-70. PubMed ID: 12892870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citalopram augmentation of antipsychotic treatment in older schizophrenia patients.
    Kasckow JW; Mohamed S; Thallasinos A; Carroll B; Zisook S; Jeste DV
    Int J Geriatr Psychiatry; 2001 Dec; 16(12):1163-7. PubMed ID: 11748776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of Baseline Suicidality With Treatment Outcome in Psychotic Depression.
    Bingham KS; Rothschild AJ; Mulsant BH; Whyte EM; Meyers BS; Banerjee S; Szanto K; Flint AJ;
    J Clin Psychiatry; 2017; 78(8):1149-1154. PubMed ID: 28445632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The InterSePT suicide scale for prediction of imminent suicidal behaviors.
    Ayer DW; Jayathilake K; Meltzer HY
    Psychiatry Res; 2008 Oct; 161(1):87-96. PubMed ID: 18786729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to intravenous antidepressant treatment by suicidal vs. nonsuicidal depressed patients.
    Pompili M; Baldessarini RJ; Tondo L; Innamorati M; Tatarelli R; Girardi P; De Pisa E
    J Affect Disord; 2010 Apr; 122(1-2):154-8. PubMed ID: 19709752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
    Barnes TR; Leeson VC; Paton C; Costelloe C; Simon J; Kiss N; Osborn D; Killaspy H; Craig TK; Lewis S; Keown P; Ismail S; Crawford M; Baldwin D; Lewis G; Geddes J; Kumar M; Pathak R; Taylor S
    Health Technol Assess; 2016 Apr; 20(29):1-46. PubMed ID: 27094189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study.
    Quante A; Regen F; Schindler F; Volkmer K; Severus E; Urbanek C; Luborzewski A; Roepke S; Anghelescu I
    Psychiatr Danub; 2013 Sep; 25(3):214-20. PubMed ID: 24048387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does age moderate the relationship between depressive symptoms and suicidal ideation in middle-aged and older patients with schizophrenia and subthreshold depression?
    Kasckow J; Golshan S; Zisook S
    Am J Geriatr Psychiatry; 2014 May; 22(5):437-41. PubMed ID: 23567374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial.
    Rucci P; Frank E; Scocco P; Calugi S; Miniati M; Fagiolini A; Cassano GB
    Depress Anxiety; 2011 Apr; 28(4):303-9. PubMed ID: 21308882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
    Perlis RH; Uher R; Perroud N; Fava M
    J Clin Psychiatry; 2012 Nov; 73(11):1439-42. PubMed ID: 23059018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
    Meltzer HY; Alphs L; Green AI; Altamura AC; Anand R; Bertoldi A; Bourgeois M; Chouinard G; Islam MZ; Kane J; Krishnan R; Lindenmayer JP; Potkin S;
    Arch Gen Psychiatry; 2003 Jan; 60(1):82-91. PubMed ID: 12511175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of subsyndromal depressive symptoms in middle-age and older patients with schizophrenia: effect of age on response.
    Kasckow J; Fellows I; Golshan S; Solorzano E; Meeks T; Zisook S
    Am J Geriatr Psychiatry; 2010 Sep; 18(9):853-7. PubMed ID: 20808103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning.
    Kasckow J; Lanouette N; Patterson T; Fellows I; Golshan S; Solorzano E; Zisook S
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):183-90. PubMed ID: 19711335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram in first episode schizophrenia: The DECIFER trial.
    Goff DC; Freudenreich O; Cather C; Holt D; Bello I; Diminich E; Tang Y; Ardekani BA; Worthington M; Zeng B; Wu R; Fan X; Li C; Troxel A; Wang J; Zhao J
    Schizophr Res; 2019 Jun; 208():331-337. PubMed ID: 30709746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability, validity and factorial structure of the Arabic version of the international suicide prevention trial (InterSePT) scale for suicidal thinking in schizophrenia patients in Doha, Qatar.
    Hammoudeh S; Ghuloum S; Mahfoud Z; Opler M; Khan A; Yehya A; Abdulhakam A; Al-Mujalli A; Hani Y; Elsherbiny R; Al-Amin H
    BMC Psychiatry; 2016 Dec; 16(1):437. PubMed ID: 27927173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram.
    Trivedi MH; Cutler AJ; Richards C; Lasser R; Geibel BB; Gao J; Sambunaris A; Patkar AA
    J Clin Psychiatry; 2013 Aug; 74(8):802-9. PubMed ID: 24021497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.